7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-06-30 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2005-09-30 2005-06-30 2005-03-31 2004-09-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-09-30 2002-06-30 2002-03-31 
      
                                                                                       
      revenues:
                                                                                       
      product revenue
    47,167,000 49,007,000 39,436,000 47,506,000 28,209,000 780,000                                                                              
      royalties
    60,000 29,000 167,000 117,000 62,000 102,000 304,000 53,500 164,000 29,000 21,000    123,000                                                                     
      total revenues
    47,227,000 49,036,000 39,603,000 7,364,250 28,271,000 882,000                              5,108,000   35,363,000         636,000 130,000 1,254,000 251,000 220,000 462,000 1,505,000 1,098,000 546,000 1,001,000 918,000 605,000 494,000 183,000 444,000 2,605,000 198,000 4,687,000 1,130,000 889,000 916,000 4,066,000 723,000 786,000 673,000 4,671,000  101,000 248,000        
      costs and operating expenses:
                                                                                       
      cost of goods sold
    1,043,000 1,190,000 1,206,000 783,000 456,000 17,000                                                                              
      research and development
    21,070,000 21,736,000 15,078,000 23,433,000 20,153,000 30,779,000 29,373,000 32,911,000 29,426,000 35,490,000 27,219,000 28,210,000 24,603,000 20,606,000 22,099,000 24,150,000 18,527,000 21,937,000 21,113,000 16,228,000 13,613,000 10,845,000 10,802,000 24,923,000 11,109,000 10,134,000 5,906,000 5,081,000 2,707,000 3,204,000 2,440,000 2,523,000 2,637,000 2,499,000 3,374,000 4,319,000 4,575,000 5,033,000 4,050,000 4,812,000 4,987,000 5,994,000 5,151,000 5,211,000 5,338,000 4,807,000 7,999,000 11,684,000 12,777,000 15,107,000             42,050,000 11,614,000 15,011,000 12,326,000 14,098,000 13,189,000 5,688,000 10,703,000 9,326,000 12,183,000 6,824,000 6,473,000 8,900,000 5,718,000 4,900,000 4,864,000 7,772,000 6,964,000 6,346,000 8,146,000 10,164,000 
      selling, general and administrative
    39,001,000 38,564,000 40,023,000 43,371,000 35,877,000 39,419,000                                                                              
      total costs and operating expenses
    61,114,000                                                                                   
      income from operations
    -13,887,000 -12,454,000 -16,704,000 -20,050,000 -28,215,000 -69,333,000 -56,134,000 -54,289,000 -47,612,000 -51,951,000 -40,092,000 -41,951,000 -39,948,000 -27,976,000 -28,675,000 -30,982,000 -25,674,000 -28,889,000 -28,454,000 -23,266,000 -20,015,000 -16,762,000 -16,870,000 -30,008,000 -15,972,000 -15,224,000 -11,301,000 -9,589,000 -6,805,000 -7,242,000 -7,437,000 -7,786,000 -7,244,000      27,020,000           -18,918,000 -30,408,000 -19,936,000 -21,416,000 -24,356,000 -59,611,000 -18,203,000 -16,876,000 -16,477,000 -18,372,000 -16,400,000 -18,757,000 -16,705,000 -51,586,000 -15,458,000 -14,336,000 -15,335,000 -16,766,000 -16,402,000 -3,346,000 -12,094,000 -11,408,000 -12,921,000 -3,897,000 -10,363,000 -10,475,000 -52,011,000 -5,483,500 -5,237,000 -8,653,000 -8,044,000 -7,442,000 -9,488,000 -11,134,000 
      yoy
    -50.78% -82.04% -70.24% -63.07% -40.74% 33.46% 40.01% 29.41% 19.18% 85.70% 39.82% 35.40% 55.60% -3.16% 0.78% 33.16% 28.27% 72.35% 68.67% -22.47% 25.31% 10.10% 49.28% 212.94% 134.71% 110.22% 51.96% 23.16% -6.06%                     -22.33% -48.99% 9.52% 26.90% 47.82% 224.47% 10.99% -10.03% -1.36% -64.39% 6.09% 30.84% 8.93% 207.68% -5.76% 328.45% 26.80% 46.97% 26.94% -14.14% 16.70% 8.91% -75.16% -28.93% 97.88% 21.06% 546.58% -26.32% -44.80% -22.28%     
      qoq
    11.51% -25.44% -16.69% -28.94% -59.31% 23.51% 3.40% 14.02% -8.35% 29.58% -4.43% 5.01% 42.79% -2.44% -7.45% 20.67% -11.13% 1.53% 22.30% 16.24% 19.41% -0.64% -43.78% 87.88% 4.91% 34.71% 17.85% 40.91% -6.03% -2.62% -4.48% 7.48%                  -37.79% 52.53% -6.91% -12.07% -59.14% 227.48% 7.86% 2.42% -10.31% 12.02% -12.57% 12.28% -67.62% 233.72% 7.83% -6.51% -8.54% 2.22% 390.20% -72.33% 6.01% -11.71% 231.56% -62.40% -1.07% -79.86% 848.50% 4.71% -39.48% 7.57% 8.09% -21.56% -14.78%  
      operating margin %
                                                                                       
      interest income
    4,264,000 4,656,000 5,152,000 5,159,000 4,877,000 5,332,000 4,239,000 4,596,000 4,965,000 4,738,000 3,853,000 1,235,000 852,000 330,000 112,000 106,000 112,000 136,000 173,000                                                                 
      interest expense
    -8,644,000 -8,516,000 -8,200,000 -8,706,000 -3,046,000 -3,319,000 -3,433,000 -2,321,000 -2,066,000 -2,003,000 -1,922,000 -2,005,000 -1,817,000 -1,581,000 -1,479,000 -1,135,000 -1,058,000 -804,000 -743,000                                                                 
      other income and (expense)
    -161,000 -61,000 -83,000 -47,000 -63,000 -63,000 -62,000 -16,000 -92,000 -11,000 39,000 229,000 -138,000 1,110,000 -56,000 -6,000 -77,000 -17,000 1,200,000                                                                 
      net income
    -18,428,000 -16,375,000 -19,835,000 -25,352,000 -26,447,000 -67,383,000 -55,390,000 -51,973,000 -44,805,000 -49,227,000 -38,122,000 -42,635,000 -41,051,000 -28,117,000 -30,098,000 -32,017,000 -26,697,000 -29,574,000 -27,824,000 -23,787,000 -19,651,000 -15,824,000 -16,355,000 -29,070,000 -15,180,000 -14,239,000 -10,059,000 -7,300,000 -5,597,000 -6,934,000 -7,186,000 -7,429,000 -6,899,000 -6,405,000 -7,183,000 -3,576,000 -8,637,000 -8,842,000 27,185,000 -9,356,000 -9,315,000 -9,549,000 -8,734,000 -8,440,000 -8,254,000 -8,947,000 -11,897,000 -15,953,000 -18,326,000 -18,739,000 -31,854,000 -19,522,000 -21,088,000 -24,389,000 -59,362,000 -18,344,000 -17,031,000 -16,640,000 -18,391,000 -15,224,000 -19,758,000 -16,811,000 -48,457,000 -13,564,000 -11,045,000 -12,834,000 -13,985,000 1,167,000 -5,585,000 -9,837,000 -9,257,000 -11,862,000 -3,082,000 -9,688,000 -10,302,000 -51,683,000 -5,581,750 -5,107,000 -9,288,000 -7,932,000 -7,196,000 -9,008,000 -10,475,000 
      yoy
    -30.32% -75.70% -64.19% -51.22% -40.97% 36.88% 45.30% 21.90% 9.14% 75.08% 26.66% 33.16% 53.77% -4.93% 8.17% 34.60% 35.86% 86.89% 70.13% -18.17% 29.45% 11.13% 62.59% 298.22% 171.22% 105.35% 39.98% -1.74% -18.87% 8.26% 0.04% 107.75% -20.12% -27.56% -126.42% -61.78% -7.28% -7.40% -411.25% 10.85% 12.85% 6.73% -26.59% -47.09% -54.96% -52.25% -62.65% -18.28% -13.10% -23.17% -46.34% 6.42% 23.82% 46.57% 222.78% 20.49% -13.80% -1.02% -62.05% 12.24% 78.89% 30.99% 246.49% -1262.30% 97.76% 30.47% 51.07% -109.84% 81.21% 1.54% -10.14% -77.05% -44.78% 89.70% 10.92% 551.58% -22.43% -43.31% -11.33%     
      qoq
    12.54% -17.44% -21.76% -4.14% -60.75% 21.65% 6.57% 16.00% -8.98% 29.13% -10.59% 3.86% 46.00% -6.58% -5.99% 19.93% -9.73% 6.29% 16.97% 21.05% 24.18% -3.25% -43.74% 91.50% 6.61% 41.55% 37.79% 30.43% -19.28% -3.51% -3.27% 7.68% 7.71% -10.83% 100.87% -58.60% -2.32% -132.53% -390.56% 0.44% -2.45% 9.33% 3.48% 2.25% -7.75% -24.80% -25.42% -12.95% -2.20% -41.17% 63.17% -7.43% -13.53% -58.91% 223.60% 7.71% 2.35% -9.52% 20.80% -22.95% 17.53% -65.31% 257.25% 22.81% -13.94% -8.23% -1298.37% -120.90% -43.22% 6.27% -21.96% 284.88% -68.19% -5.96% -80.07% 825.93% 9.30% -45.02% 17.10% 10.23% -20.12% -14.00%  
      net income margin %
                                                                                       
      basic and diluted net income per share
    -0.03 -0.02 -0.03 -0.04 -0.04 -0.1 -0.09 -0.09 -0.08 -0.09 -0.07 -0.11 -0.1 -0.07 -0.09 -0.09 -0.08 -0.09 -0.09 -0.08 -0.06 -0.06 -0.08 -0.15 -0.08 -0.08 -0.05 -0.04 -0.03 -0.04 -0.04 -0.033 -0.04 -0.04 -0.05  -0.05 -0.06  -0.06 -0.06 -0.06 -0.06 -0.06 -0.06 -0.07 -0.09 -0.13 -0.14 -0.15 -0.13 -0.16 -0.17 -0.2    -0.18    -0.2       -0.108 -0.15 -0.14 -0.21 -0.06 -0.18 -0.23 -1.28 -0.19 -0.15 -0.32 -0.32 -0.29 -0.37 -0.43 
      shares used in computing basic and diluted net income per share
    667,101,756 666,170,358 665,905,469 6,099,635 662,158,182 653,904,978 603,493,451 8,199,828 579,508,305 547,280,946 544,459,004 125,797 405,237,474 403,868,713 332,066,889 1,079,051 328,934,491 327,026,907 323,638,696 15,899,486 318,799,174 246,966,143 200,222,092 2,792,690 189,123,647 186,556,082 186,393,128 3,317,243 184,301,986 174,475,244 160,525,947 39,796,713.25 159,216,642 159,182,367 159,161,550  158,998,931 158,896,038  158,066,910 157,547,568 156,843,989 156,706,196 143,465,818 128,293,074 128,162,993 127,982,931 127,236,993 126,891,909 126,372,846    123,098,728    95,012,100    84,160,889                      
      total operating expenses
     61,490,000 56,307,000 67,587,000 56,486,000 70,215,000 56,438,000 54,312,000 47,776,000 51,980,000 40,113,000 42,054,000 40,245,000 28,049,000 28,798,000 32,022,000 25,783,000 28,996,000 28,591,000 23,316,000 20,123,000 16,805,000 16,922,000 30,179,000 16,103,000 15,325,000 11,358,000 9,964,000 6,970,000 7,450,000 7,755,000 7,977,000 7,407,000 6,905,000 8,031,000 8,985,000 9,122,000 9,826,000 8,343,000 9,730,000 9,993,000 10,067,000 9,004,000 9,205,000 8,914,000 9,077,000 12,750,000 16,513,000 18,609,000 20,172,000 30,659,000 20,156,000 21,878,000 25,861,000 60,709,000 18,749,000 17,877,000 17,395,000 18,977,000 16,894,000 18,940,000 17,149,000 54,191,000 15,656,000 19,023,000 16,465,000 17,655,000 17,318,000 7,412,000 12,817,000 12,194,000 13,594,000 8,568,000 10,422,000 10,576,000 52,259,000        
      operating expenses:
                                                                                       
      general and administrative
          27,065,000 21,401,000 18,350,000 16,490,000 12,894,000 13,844,000 15,642,000 7,443,000 6,699,000 7,872,000 7,256,000 7,059,000 7,478,000 7,088,000 6,510,000 5,960,000 6,120,000 5,256,000 4,994,000 5,191,000 5,452,000 4,883,000 4,263,000 4,246,000 5,315,000 5,454,000 4,770,000 4,406,000 4,657,000 4,666,000 4,547,000 4,793,000 4,334,000 3,977,000 4,600,000 4,073,000 3,853,000 3,994,000 3,460,000 3,432,000 4,751,000 4,829,000 5,832,000 5,065,000 5,538,000 3,811,000 5,334,000 9,106,000 4,684,000 5,021,000 4,488,000 3,850,000 3,638,000 3,499,000 3,828,000 3,378,000 12,141,000 4,042,000 4,012,000 4,139,000 3,557,000 4,129,000 1,724,000 2,114,000 2,868,000 1,411,000 1,744,000 3,949,000 1,676,000 1,391,000 838,250 845,000 1,166,000 1,342,000 1,314,000 1,453,000 1,596,000 
      license fees and royalties
               103,000 297,000 73,000  1,040,000 109,000 107,000 137,000 50,000 108,000 43,000 52,000 171,000 131,000 101,000 57,000 375,000 165,000 208,000 318,000 191,000 163,000 174,000 537,000 5,108,000 211,000 749,000 363,000 251,000 537,000 160,000 341,000 474,000 181,000 112,000 765,000 636,000 130,000 1,254,000 251,000 220,000 312,000 1,355,000 453,000 343,000 776,000 693,000     2,398,000 111,000 4,612,000 1,130,000 585,000 623,000 4,141,000 524,000 675,000 606,000 4,620,000 59,000 101,000 248,000 236,750 472,000 249,000 226,000 200,000 96,000 111,000 
      change in fair value of equity investment
                       -49,000 -118,000 422,000 -195,000  -195,000 -98,000 98,000 -271,000 205,000 -350,000 -125,000                                                     
      interest and other income
                       433,250 504,000 475,000 754,000 925,000 1,021,000 1,113,000 1,162,000 1,120,000 1,060,000 717,000 394,000 375,000 363,000 346,000 332,000 322,000 293,000 256,000 187,000 145,000 149,000 91,000 99,000 83,000 699,000 56,000 81,000 140,000 165,000 176,000 204,000 237,000 287,000 296,000 1,426,000 223,000 194,000 202,000 246,000 240,000 363,000 525,000 4,119,000 1,423,000 2,384,000 2,772,000 2,843,000 2,792,000 -1,706,000 2,283,000 2,189,000 1,105,000 998,000 847,000 348,000 498,000 239,250 287,000 394,000 276,000 434,000 665,000 871,000 
      other income
                         41,000 -44,000 13,000 -34,000 -30,000 -18,000 -20,000 -57,000 -59,000                                                      
      collaboration revenue
                                          35,000,000                                             
      restructuring charges
                                           941,000 406,000    116,000 838,000                                      
      unrealized gain on derivatives
                                            16,000 289,000  224,000   25,000  8,000  142,500 291,000 240,000  33,250 -97,000 172,000 58,000 -71,750 966,000 -1,330,000  123,750 495,000 931,000 -247,000 -36,000 14,805,000                
      net income per share
                                                              -0.148 -0.17                        
      basic
                                       -0.02   0.17                                             
      diluted
                                       -0.02   0.17                                             
      shares used in computing net income per share:
                                                                                       
      basic
                                       159,140,254   158,151,747                                             
      diluted
                                       159,140,254   162,669,681                                             
      unrealized loss on derivatives
                                                                                       
      revenues from collaborative agreements
                                                        150,000 150,000 163,250 203,000 225,000 225,000     207,000 87,000 75,000   293,000 -75,000 199,000 111,000 67,000 51,000    18,000  36,000 36,000 18,000 15,000 515,000 
      losses recognized under equity method investment
                                                        -168,000 -335,000 -1,212,000 -243,000 -496,000 -396,000 -164,000   -656,000                      
      unrealized gain on fair value of derivatives
                                                     26,000    39,000        77,000                      
      research and development (including amounts
                                                                                       
      for related parties: three months - 2011-none;
                                                                                       
      2010-53; nine months – 2011-none; 2010-697)
                                                      12,411,000 16,345,000                                
      shares used in computing basic and diluted net income
                                                                                       
      per share
                                                      31,064,924.5 125,101,177 124,579,190                               
      research and development (including amounts for
                                                                                       
      related parties: three months - 2011-none; 2010-
                                                                                       
      317; six months – 2011-none; 2010-644)
                                                        16,544,000                               
      for related parties: 2011-none, 2010-327)
                                                         16,755,000                              
      related parties: three months – 2010-53; 2009-
                                                                                       
      397; nine months – 2010-697; 2009-1,328)
                                                          10,165,500 13,728,000                            
      deemed dividend on derivatives
                                                                -190,000    -5,420,000   -3,661,000                
      net income applicable to common stockholders
                                                          -59,362,000 -18,344,000 -17,031,000  -12,995,750 -15,224,000 -19,948,000  -3,391,000 -13,564,000 -7,328,250 -12,834,000 -13,985,000 -2,494,000                
      basic and diluted net income per share applicable to
                                                                                       
      common stockholders
                                                          97,601,520.54 -0.19 -0.18                           
      per share applicable to common stockholders
                                                          24,100,069 97,476,668 96,712,059                           
      related parties: three months - 2010-317; 2009-
                                                                                       
      502; six months – 2010-644; 2009-931)
                                                            13,389,000                           
      for related parties: 2010-327, 2009-429)
                                                             13,545,000                          
      revenues from collaborative
                                                                                       
      agreements (including amounts from related
                                                                                       
      parties: three months - 2009-none, 2008-20;
                                                                                       
      nine months - 2009-none, 2008-79)
                                                              56,250 225,000                        
      license fees and royalties (including amounts
                                                                                       
      from related parties: three months -
                                                                                       
      2009-none, 2008-none; nine months -
                                                                                       
      2009-none, 2008-1,500)
                                                              224,000 269,000                        
      research and development (including
                                                                                       
      amounts for related parties:
                                                                                       
      three months - 2009-397, 2008-184;
                                                                                       
      nine months - 2009-1,328, 2008-502)
                                                              10,569,500 13,395,000                        
      basic and diluted net income per share applicable
                                                                                       
      to common stockholders
                                                                                       
      net income per share
                                                              -0.148 -0.17                        
      shares used in computing net income per share
                                                                                       
      applicable to common stockholders
                                                              708,196 89,402,642 88,547,553                       
      parties: three months - 2009-none; 2008-
                                                                                       
      33; six months - 2009-none; 2008-59)
                                                                                       
      from related parties: three months - 2009-none;
                                                                                       
      2008-none; six months - 2009-none; 2008-
                                                                                       
      1,500)
                                                                183,000                       
      amounts for related parties: three months -
                                                                                       
      2009-502; 2008-169; six months - 2009-
                                                                                       
      931; 2008-318)
                                                                15,112,000                       
      losses recognized under equity method
                                                                                       
      investment
                                                                                       
      stockholders
                                                                -0.23                       
      revenues from collaborative agreements (including amounts from
                                                                                       
      related parties: 2009-none, 2008-26)
                                                                                       
      license fees and royalties (including amounts from related
                                                                                       
      parties: 2009-none, 2008-1,500)
                                                                 444,000                      
      research and development (including amounts for related
                                                                                       
      parties: 2009-429, 2008-149)
                                                                 13,771,000                      
      basic and diluted net income per share applicable to common stockholders
                                                                  -0.043 -0.17 -0.1 -0.17 -0.19 -0.03                
      shares used in computing basic and diluted net income per share applicable to common stockholders
                                                                  19,535,544 78,142,176 18,433,289.75 75,324,687 74,077,733 71,797,056                
      equity in losses in joint venture
                                                                                       
      weighted-average shares used for eps calculation
                                                                         66,166,827 65,932,548 57,225,184 55,301,745 54,175,184  40,449,815  33,189,213 29,452,031 24,935,574 24,737,635 24,674,456 24,490,391 
      acquired in-process research technology
                                                                               45,150,000        
      equity in losses of joint venture
                                                                            -12,000           
      acquired in-process research
                                                                                       
      technology
                                                                                       
      debenture conversion expense
                                                                                -194,750  -779,000     
      computing basic and diluted net
                                                                                       
      loss per share
                                                                              45,442,854         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.